Finance

Lists
SEPN:NASDAQ
Septerna Inc
$42.60
+1.77%
(+0.74) 1D
$42.60
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SEPN...
Open
$41.27
High
$42.88
Low
$40.60
Mkt. cap
2.03B
Avg. vol.
435.24K
Volume
337.79K
52-wk high
$53.34
52-wk low
$19.69
EPS
-$1.29
Shares outstanding
47.55M
No. of employees
134
Open
$41.27
High
$42.88
Low
$40.60
Mkt. cap
2.03B
Avg. vol.
435.24K
Volume
337.79K
52-wk high
$53.34
52-wk low
$19.69
EPS
-$1.29
Shares outstanding
47.55M
No. of employees
134
News stories
From web sources and news partners
About Septerna Inc
CEO-
Employees134
Founded2019
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitesepterna.com
Analyst ratings
Based on 6 analysts giving stock ratings to SEPN in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SEPN in the last 3 months.
Highest
Current $42.60
$65.00 (+52.58%)
Average
$59.00 (+38.50%)
Lowest
$48.00 (+12.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alex Thompson CFA
Stifel Nicolaus
Buy
Reiterated
$60.00
+40.8%
11/10/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
$60.00
+40.8%
11/09/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$61.00
+43.2%
11/10/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$60.00
+40.8%
11/10/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
$65.00
+52.6%
11/06/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
$48.00
+12.7%
08/19/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
$59.00
+38.5%
08/13/2026
Yaron Werber
TD Cowen
Buy
Maintained
-
-
08/11/2026
Martin Auster
Raymond James
Buy
Reiterated
$49.00
+15%
08/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
24.12M
26.52M
26.75M
18.88M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
31.86M
29.54M
35.13M
36.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.28M
10.29M
8.45M
9.55M
Operating expense
40.14M
39.82M
43.58M
46.11M
Total operating expenses
40.14M
39.82M
43.58M
46.11M
Operating income
-16.02M
-13.30M
-16.84M
-27.23M
Other non operating income
-41.00K
-31.00K
-23.00K
-12.00K
EBT including unusual items
-10.73M
-8.30M
-12.06M
-21.97M
EBT excluding unusual items
-10.73M
-8.30M
-12.06M
-21.97M
Income tax expense
12.00K
337.00K
973.00K
4.62M
Effective tax rate
-0.11%
-4.06%
-8.07%
-21.03%
Other operating expenses
-
-
-
-
Net income
-10.74M
-8.64M
-13.03M
-26.59M
Net profit margin
-44.52%
-32.56%
-48.73%
-140.83%
Earnings per share
-0.24
-0.19
-0.29
-0.57
Interest and investment income
5.34M
5.03M
4.80M
5.27M
Interest expense
-
-
-
-
Net interest expenses
5.34M
5.03M
4.80M
5.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.62M
-12.88M
-16.41M
-26.84M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps